Condition: HNSCC · Sponsor: Oslo University Hospital
A national, randomized, clinical trial (phase III) investigating radiotherapy with protons compared with photons for patients with squamous cell carcinoma of the head and neck area eligible for radiotherapy, either radical or postoperative, with curative intent. Comparative dose plans with protons and photons will be prepared, and the probability of toxicity evaluated with NTCP models. Patients with presumed benefit from protons will be randomized 1:1 to treatment with protons or photons. The number of randomized participants will be 400. The primary endpoint is "combined toxicity burden" - dry mouth, difficulty swallowing, pain and affected speech in the period after the end of radiotherapy to 12 months after treatment.
This description comes directly from the study's public registry record.
Barbro Berggren, Cand.Scient · 004722934000 · barbbe@ous-hf.no
Always discuss trial participation with your own doctor first.
| Haukeland University Hospital | Bergen, Norway | Not Yet Recruiting |
| Oslo University Hospital, Radiumhospitalet | Oslo, Norway | Recruiting |
| University Hospital of Northern Norway | Tromsø, Norway | Not Yet Recruiting |
| St. Olavs Hospital | Trondheim, Norway | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07580300